Search results for "comorbiditie"

showing 10 items of 43 documents

Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry

2022

Background: Currently, diabetes represents the seventh leading cause of death worldwide, with a significant economic burden. The number and severity of comorbidities increase with age, and are identified as important determinants that influence the prognosis. We aimed to investigate comorbidities and outcomes in a cohort of hospitalized elderly patients affected by diabetes. Methods: In this observational study, we retrospectively analyzed data collected from the REgistro dei pazienti per lo studio delle POlipatologie e politerapie in reparti della rete Simi (RePoSi) registry. Socio-demographic, clinical characteristics, and laboratory findings were considered. The association between varia…

Leadership and Management1-year mortality cancer comorbidities diabetes heart rate in-hospital mortality male sex.Heart rateSocio-culturaleHealth InformaticscomorbiditiesArticleComorbiditiesHealth Information Managementdiabetes; comorbidities; heart rate; cancer; male sex; in-hospital mortality; 1-year mortalityheart ratecancer1-year mortality; Cancer; Comorbidities; Diabetes; Heart rate; In-hospital mortality; Male sexLS4_4Cancerdiabetesmale sexHealth PolicyDiabetesRMale sexIn-hospital mortality1-year mortalityMedicine1-year mortality Cancer Comorbidities Diabetes Heart rate In-hospital mortality Malein-hospital mortality
researchProduct

Comorbidity does not mean clinical complexity: evidence from the RePoSI register

2019

In the last 2–3 decades internists have confronted dramatic changes in the pattern of patients acutely admitted to hospital wards. Internists observed a shift from younger subjects affected by a single organ disease to more complex patients, usually older, with multiple chronic conditions, attended by different specialists, with poor integration and treated with multiple drugs. In this regard, the concept of complex patients is addressed daily in clinical practice even if there is no agreed definition of patient complexity. To try to evaluate clinical complexity different instruments have been proposed. Among these, the number of comorbidities (NoC) was considered a marker of clinical compl…

Malemedicine.medical_specialtyCumulative illness rating scaleComorbidityDisease030204 cardiovascular system & hematologyAge and sexSeverity of Illness Index03 medical and health sciences0302 clinical medicineNumber of comorbiditiesRisk FactorsRating scaleCause of DeathInternal MedicineHumansMedicineClinical significanceHospital MortalityRegistries030212 general & internal medicineGeriatric AssessmentAgedRetrospective StudiesAged 80 and overbusiness.industryMultimorbidityLength of Staymedicine.diseaseComorbidityClinical complexityClinical PracticeItalyClinical complexity; Cumulative illness rating scale; Multimorbidity; Number of comorbiditiesEmergency medicineEmergency MedicineFemaleMultiple Chronic ConditionsbusinessComorbidity index
researchProduct

Comorbidities and quality of life in obstructed adults in a primary care setting

2016

Introduction: Comorbidities are known to impair Quality of Life (QoL)in patients with chronic obstruction pulmonary disease. A poor QoL is associated with higher dyspnoea perception. How comorbidities influence QoL in these patients is limited and needs clarification. Aim: To study the role of dyspnoea perception in the relationship between comorbidities number and QoL in obstructed and not obstructed adults in a primary care setting. Methods: Seventeen general practitioners participated to the study: 566 adults, attending the Practitioner9s study for any reason, performed spirometry and fulfilled a respiratory questionnaire between January and June 2014. 259 adults (148 M, aged 40-88) acce…

Spirometrymedicine.medical_specialtyQuality of life. Spirometry Comorbiditiesmedicine.diagnostic_testbusiness.industrySignificant differencePrimary caremedicine.diseaseComorbidityMental healthhumanitiesFEV1/FVC ratioQuality of lifemedicineGlobal healthPhysical therapybusiness
researchProduct

Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.

2017

Purpose: Literature data indicate that the proportion of patients with recent hip fracture who receive a prescription for anti-osteoporotic drugs is low and does not seem to increase over time. This study aimed to obtain data on the prescription for anti-osteoporotic drugs in Italian patients discharged after a recent hip fracture and to assess which variables could have influenced the decision for prescribing osteoporosis medication. Methods: A total of four Italian centres located in four different geographical areas (Siena, Verona, Naples and Palermo) participated in this retrospective study. In each centre, experienced clinicians gathered the data of up to 200 consecutive patients disch…

Malemedicine.medical_specialtyPediatricsHip fracture; Anti-osteoporotic drugs; Comorbidities; Ca/vitamin D supplementsAgingAnti-osteoporotic drugs; Ca/vitamin D supplements; Comorbidities; Hip fractureAnti-osteoporotic drugOsteoporosisAlternative medicine030209 endocrinology & metabolismComorbiditiesHip fracture03 medical and health sciences0302 clinical medicineSex FactorsSurveys and QuestionnairesmedicineHumans030212 general & internal medicineMedical prescriptionPractice Patterns Physicians'AgedRetrospective StudiesAged 80 and overHip fractureBone Density Conservation AgentsGeriatrics gerontologybusiness.industryHip FracturesSettore MED/34 - Medicina Fisica E RiabilitativaRetrospective cohort studyMean ageMiddle Agedmedicine.diseaseCa/vitamin D supplementsHospitalizationAnti-osteoporotic drugsItalyAnti osteoporosisPhysical therapyAnti-osteoporotic drugs; Ca/vitamin D supplements; Comorbidities; Hip fracture; Aging; Geriatrics and GerontologyOsteoporosisFemaleCa/vitamin D supplementComorbiditieGeriatrics and GerontologybusinessOsteoporotic FracturesAging clinical and experimental research
researchProduct

Positive Airway Pressure Treatment Reduces Glycated Hemoglobin (HbA1c) Levels in Obstructive Sleep Apnea Patients: Longitudinal Data from the Esada

2019

European-Respiratory-Society (ERS) International Congress -- SEP 28-OCT 02, 2019 -- Madrid, SPAIN

medicine.medical_specialtyLongitudinal dataGastroenterologyComorbidities03 medical and health sciencesHba1c levelchemistry.chemical_compound0302 clinical medicineDiabetes mellitusInternal medicinePositive airway pressuremedicine030212 general & internal medicinebusiness.industryType 2 Diabetes MellitusSleep apneaSystemic effectmedicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemApnea–hypopnea indexchemistryCardiologyGlycated hemoglobinbusinessBody mass indexTurkish Thoracic Journal
researchProduct

Adult-onset Still's disease with elderly onset: results from a multicentre study

2021

Objective In this study, we aimed to describe the clinical characteristics, life-threatening complications occurrence, and mortality of adult-onset Still's disease (AOSD) patients with elderly onset. Methods A multicentre retrospective study of prospectively followed-up AOSD patients included in Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort was performed. Results Out of 221 assessed patients, 37 (16.7%) had an onset of the disease aged over 60 years. When compared with younger patients, these were characterised by a higher prevalence of pericarditis (p=0.008), comorbidities (p < 0.0001), and mortality (p=0.023). Age predicted the presence of serositis …

Lung DiseasesAdult-OnsetAdultcomorbiditieImmunologyadult-onset Still's diseasecomorbiditiesLung Diseaseserositisadult-onset Still's disease; aging; serositis; parenchymal lung disease; comorbidities; Adult; Aged; Humans; Middle Aged; Retrospective Studies; Lung Diseases; Macrophage Activation Syndrome; Serositis; Still's Disease Adult-OnsetRheumatologyRetrospective StudieImmunology and AllergyHumansRetrospective StudiesAgedcomorbidities.SerositiMacrophage Activation SyndromeagingMiddle AgedStill's Diseaseadult-onset Still's disease; aging; serositis; parenchymal lung disease; comorbiditiesStill's Disease Adult-Onsetparenchymal lung diseaseHuman
researchProduct

Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

2020

Abstract Background The clinical and laboratory features of patients enrolled in the Severe Asthma Network in Italy (SANI) registry, a web-based observatory collecting demographic, clinical, functional and inflammatory data of patients with severe asthma were evaluated, with a special emphasis to chronic rhinosinusitis with nasal polyposis (CRSwNP). Methods For each eligible patients the following information has been collected: demographic data, clinical features, asthma control in the previous month according to the GINA (Global INitiative for Asthma) Guidelines and standardized questionnaires, concomitant regular and on demand treatments and inflammatory markers. Results 695 patients wit…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtySevere asthmaDatabases FactualAdministration OralComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioNitric OxideSeverity of Illness IndexComorbiditiesOral corticosteroidAdrenal Cortex HormonesInternal medicineSeverity of illnessOral corticosteroidsmedicinePrevalenceNasal polypsHumansNasal polypsRegistriesSinusitisSinusitisAsthmaAgedRhinitisInternetBronchiectasisbusiness.industryNasal polypSettore MED/09 - MEDICINA INTERNAAtopic dermatitisComorbidities; Nasal polyps; Oral corticosteroids; Severe asthmaMiddle Agedmedicine.diseaseComorbidityAsthmaComorbidities Nasal polyps Oral corticosteroids Severe asthmaItalyConcomitantChronic DiseaseDisease ProgressionFemaleComorbiditiebusiness
researchProduct

Current and future challenges in HCV: insights from an Italian experts panel

2017

Background: The recent availability of direct acting antiviral drugs (DAAs) has drastically changed hepatitis C virus (HCV) treatment scenarios, due to the exceedingly high rates of sustained virological response (SVR) and excellent tolerability allowing for treatment at all disease stages. Methods: A panel of Italian experts was convened twice, in November 2016 and January 2017, to provide further support on some open issues and provide guidance for personalized HCV care, also in light of forthcoming regimens. Results and conclusions: Treatment recommendations issued by international and national liver societies to guide clinicians in the management of HCV infection are constantly updated …

Microbiology (medical)medicine.medical_specialtySettore MED/17 - Malattie InfettiveDisease stagesComorbidityAntiviral AgentsComorbiditiesVirological response03 medical and health sciences0302 clinical medicineComorbidities; DAAs; HCV; Treatment; Microbiology (medical); Infectious DiseasesmedicineHumans030212 general & internal medicineIntensive care medicineDAAHigh rateComorbidities; DAAs; HCV; Treatmentbusiness.industryDAAsGeneral MedicineHepatitis Cmedicine.diseaseHepatitis CVirologyTreatmentInfectious DiseasesItalyTolerabilityComorbidities; DAAs; HCV; Treatment; Comorbidity; Hepatitis C; Humans; Italy; Antiviral AgentsHealthcare settingsHCV030211 gastroenterology & hepatologyComorbiditiebusinessDirect acting
researchProduct

[Psychocognitive and psychiatric disorders associated with developmental dyslexia: A clinical and scientific issue].

2008

Abstract INTRODUCTION: Dyslexia is a complex neurodevelopemental disorder that affects 5 to 10% of school-age children. This condition consists in a specific learning disability with a neurological origin. These learning difficulties are unexpected in relation to other cognitive abilities and the provision of efficient classroom instruction. A range of neurobiological investigations suggests that disruption of the parieto-temporo-occipital systems underlies a failure of skilled reading to develop. The observation that dyslexia is both a familial and heritable problem was made early on and was confirmed by twin studies. They also suggested that both genetic and environmental factors are invo…

DyslexiaCross-Sectional StudiesRisk FactorsMental DisordersHumansDevelopmental dyslexia Psychiatric comorbidities ADHD Learning disabilitiesComorbidityChildCognition DisordersSettore MED/39 - Neuropsichiatria InfantileL'Encephale
researchProduct

Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome

2021

Background and Objectives: Obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) are usually associated with multi-morbidity. The aim of this study was to retrospectively investigate the prevalence of comorbidities in a cohort of patients with OSAS and COPD-OSAS overlap syndrome (OS) patients and to explore differences between these two groups. Materials and Methods: Included were consecutive OS patients and OSAS patients who had been referred to our sleep laboratory, and were matched in terms of sex, age, BMI, and smoking history. Presence of comorbidities was recorded based on their medical history and after clinical and laboratory examination. Results: …

comorbiditiemedicine.medical_specialtyMedicine (General)obstructive sleep apnea syndromeComorbiditySettore MED/10 - Malattie Dell'Apparato Respiratoriooverlap syndromecomorbiditiesArticlechronic obstructive pulmonary diseaseFEV1/FVC ratioPulmonary Disease Chronic ObstructiveR5-920cardiovascular diseaseInternal medicinemedicineHumansRetrospective StudiesCOPDSleep Apnea Obstructivebusiness.industryOverlap syndromeGeneral Medicinemedicine.diseaseComorbiditynervous system diseasesRespiratory Function Testsrespiratory tract diseasesObstructive sleep apneaApnea–hypopnea indexCohortbusinessDyslipidemiaMedicina
researchProduct